GDRX News and Press, GoodRx Holdings Inc.

GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its second quarter 2024 financial results before U.S. markets open on Thursday, August 8, 2024. GoodRx management ...

Former Genentech CEO brings over 35 years of pharmaceutical and healthcare expertise to GoodRx GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced the ...

2024-06-29 15:44:55 ET More on Eli Lilly, Novo Nordisk, etc. Novo Nordisk Breaks Out To An All-Time High On China Approval Of Wegovy Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis) Eli Lilly: The Party Is Probably Nearing The End ...

Consumers have paid $21 billion out-of-pocket on prescription medications in 2024, an average of $16.26 per prescription Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., debuted its new Prescription Cost Tracker where it will monitor out-of-po...

2024-06-10 07:00:04 ET Craig Hettenbach from Morgan Stanley issued a price target of $9.50 for GDRX on 2024-06-10 05:32:00. The adjusted price target was set to $9.50. At the time of the announcement, GDRX was trading at $8.55. The overall price target consensus is at $1...

2024-05-31 07:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Former Dell Technologies and Skype Board member brings decades of tech, strategy and management experience to GoodRx GoodRx (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., today announced the election of Simon Patterson to its Board of Directors. Currently ...

GoodRx honored for creating new ways to deliver significant savings on prescription medications Today, GoodRx (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., was named to the fourth-annual TIME100 Most Influential Companies list , which highlights...

2024-05-28 01:32:25 ET Summary GoodRx has seen a ~30% increase in its share price this year due to fundamental improvements and raised growth outlook. The company has seen a rebound in pharmacy transactions, leading to two straight quarters of revenue growth after spending 2023 in...

2024-05-23 12:36:23 ET More on GoodRx Holdings GoodRx Holdings, Inc. (GDRX) Q1 2024 Earnings Call Transcript GoodRx Holdings: Large TAM Continues To Support Growth GoodRx Holdings, Inc. (GDRX) Q4 2023 Earnings Call Transcript GoodRx rallies for second day ami...